Clinical Trials Browser

Metastatic Castration-resistant Prostate Neoplasms × Clear all

NCT05818683 2026-02-13

A Study of JNJ-78278343 in Combination With Either JNJ-63723283 (Cetrelimab), Taxane Chemotherapy, or Androgen Receptor Pathway Inhibitors for Metastatic Prostate Cancer

Phase 1 Recruiting

Metastatic Castration-resistant Prostate Neoplasms

NCT07164443 2025-12-19

KLK2-comPAS

Phase 3 Recruiting

Metastatic Castration-resistant Prostate Neoplasms